TABLE 3
FROM:
Increased Expression of FGF-8 Isoforms and FGF Receptors in Human Premalignant Prostatic Intraepithelial Neoplasia Lesions and Prostate Cancer
Eeva M Valve, Marja T Nevalainen, Martti J Nurmi, Matti K Laato, Paula M Martikainen and Pirkko L Härkönen
BACK TO ARTICLETable 3. Summary of the Results of Immunohistochemical Stainings for FGF-8 and FGFR1 and FGFR2 in Prostates from Cystoprostatectomies
| Prostates from cystoprostatectomies | FGF-8 | FGFR1 | FGFR2 | |||
|---|---|---|---|---|---|---|
| Normal | PIN | Normal | PIN | Normal | PIN | |
| P25 | 0 | 0 | 0/+ | ++ | 0/+ | ++ |
| P26 | 0/+ | +/++ | 0/+ | ++ | 0/+ | ++ |
| P40 | 0/+ | +/++ | ++ | ++ | + | +/++ |
| P44 | 0/+ | - | ++ | - | + | - |
| P45 | 0 | - | 0/+ | - | 0/+ | - |
| P63 | 0 | + | 0/+ | +/++ | 0/+ | +/++ |
| P93 | 0/+ | + | +/++ | ++ | 0/+ | + |
PIN, prostatic intraepithelial neoplasia; -, no PIN lesions in the sample.
Intensity of immunoreactivity: 0, none; +, weak, ++, moderate; +++, strong; 0/+, 0/++, 0/+++, +/++, +/+++, ++/+++: heterogenous distribution of immunoreactivity.
